Press Coverage

Adularia’s Journey Highlighted in Founded Interview

Our CEO, Dr. Ana Montalban-Arques, spoke with Founded about Adularia’s journey and our new approach in cancer therapy. The article...

Aug 211 min read

In a fascinating episode of the X-Health.show podcast, Ana Montalban-Arques, CEO of Recolony, discusses the potential of gut microbiota...

Apr 22, 20241 min read

Ana Montalban-Arques, was recently featured on the Swisspreneur podcast, where she discussed our bacteria-based cancer therapy and shared...

Feb 29, 20241 min read

Recolony ranks 10th in this annual ranking created by 100 leading investors and industry experts of the Swiss Startup scene.

Oct 4, 20231 min read

Recolony enters the prestigious Top100 Swiss Startups ranking as newcomer in its first year of existence. The TOP 100 Swiss Startup Award...

Sep 9, 20231 min read

Philipp Busenhart, CBO of Recolony, presents our company in this interview with the Handelzeitung

Apr 20, 20231 min read

SWICA September Newsletter includes an article about Recolony Source: Swiss.ch

Sep 14, 20221 min read

Sep 11, 20220 min read

Recolony has been selected to be part of the Swiss National Startup Team 2022 and will join Venture Leaders Biotech next September in...

Jul 25, 20221 min read

Ana Montalban-Arques got interviewed by the University of Zurich to talk about our bacteria-based cancer therapy for the treatment of...

Apr 21, 20221 min read

Our article "Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors" is highlighted in the...

Oct 15, 20211 min read